Amgen Inc. buy BMO Capital Markets
Start price
03.05.24
/
50%
€292.50
Target price
03.05.25
€329.44
Performance (%)
-15.61%
End price
04.05.25
€246.85
Summary
This prediction ended on 04.05.25 with a price of €246.85. The price of Amgen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.61%. BMO_Capital_Markets has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. A total of €8.50 was paid as dividends for this prediction. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | 1.641% | 1.641% | 8.928% |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at BMO Capital Markets from $336.00 to $355.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten